ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Pancreatic Cancer
Clinical trial NCT02362048 · COMPLETED
Trial details
- NCT number
- NCT02362048
- Sponsor
- Acerta Pharma BV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2017-03-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.